Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 142,208 shares at $53.01 ($7.6M) on 2020-10-07, disclosed to the SEC on 2020-10-09.
Open-market sale of $7.6M PTCT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.94 | 16,494 | $873K | 11.5% |
| 2 | $52.94 | 16,494 | $873K | 11.5% |
| 3 | $53.01 | 11,143 | $591K | 7.8% |
| 4 | $53.01 | 11,143 | $591K | 7.8% |
| 5 | $53.62 | 31,681 | $1.7M | 22.4% |
| 6 | $53.62 | 31,681 |
| $1.7M |
| 22.4% |
| 7 | $53.69 | 11,786 | $633K | 8.3% |
| 8 | $53.69 | 11,786 | $633K | 8.3% |
| Total | $53.38 avg | 142,208 | $7.6M | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |